J Mol Cell Cardiol

• 

  Publication Venue For

  • Meta-analysis of cardiomyopathy-associated variants in troponin genes identifies loci and intragenic hot spots that are associated with worse clinical outcomes..  142:118-125. 2020
  • Clinical-pathological correlations of BAV and the attendant thoracic aortopathies. Part 1: Pluridisciplinary perspective on their hemodynamics and morphomechanics..  133:223-232. 2019
  • Clinical-pathological correlations of BAV and the attendant thoracic aortopathies. Part 2: Pluridisciplinary perspective on their genetic and molecular origins..  133:233-246. 2019
  • Morphomechanic phenotypic variability of sarcomeric cardiomyopathies: A multifactorial polygenic perspective..  126:23-35. 2019
  • Insights from molecular signature of in vivo cardiac c-Kit(+) cells following cardiac injury and β-catenin inhibition..  123:64-74. 2018
  • Implementing genome-driven personalized cardiology in clinical practice..  115:142-157. 2018
  • Conditional knockout of Fgf13 in murine hearts increases arrhythmia susceptibility and reveals novel ion channel modulatory roles..  104:63-74. 2017
  • A computational model of cardiac fibroblast signaling predicts context-dependent drivers of myofibroblast differentiation..  94:72-81. 2016
  • Computational modeling of cardiac fibroblasts and fibrosis..  93:73-83. 2016
  • Modifying the mechanics of healing infarcts: Is better the enemy of good?.  93:115-124. 2016
  • A novel NaV1.5 voltage sensor mutation associated with severe atrial and ventricular arrhythmias..  92:52-62. 2016
  • Gene signatures of postoperative atrial fibrillation in atrial tissue after coronary artery bypass grafting surgery in patients receiving β-blockers..  92:109-115. 2016
  • Inhibition of Wnt6 by Sfrp2 regulates adult cardiac progenitor cell differentiation by differential modulation of Wnt pathways..  85:215-225. 2015
  • Calcium signaling regulates ventricular hypertrophy during development independent of contraction or blood flow..  80:1-9. 2015
  • HASF is a stem cell paracrine factor that activates PKC epsilon mediated cytoprotection..  66:157-164. 2014
  • Overexpression of TNNI3K, a cardiac-specific MAPKKK, promotes cardiac dysfunction..  54:101-111. 2013
  • Β-arrestin: a signaling molecule and potential therapeutic target for heart failure..  51:534-541. 2011
  • Mesenchymal stem cells stimulate protective genetic reprogramming of injured cardiac ventricular myocytes..  50:346-356. 2011
  • Paracrine mechanisms of stem cell reparative and regenerative actions in the heart..  50:280-289. 2011
  • Bone morphogenetic protein 4 mediates myocardial ischemic injury through JNK-dependent signaling pathway..  48:1255-1265. 2010
  • Extracellular superoxide dismutase regulates cardiac function and fibrosis..  47:730-742. 2009
  • Physiologic and cardiac roles of beta-arrestins..  46:300-308. 2009
  • Secreted frizzled related protein 2 protects cells from apoptosis by blocking the effect of canonical Wnt3a..  46:370-377. 2009
  • Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C..  45:281-288. 2008